NeuLive Medical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

NeuLive Medical General Information

Description

Developer of neurological devices designed to treat ischemic stroke, pain, epilepsy, Parkinson's, obsessive-compulsive disorder, and other neurological diseases. The company focuses on stroke and hemorrhage products such as dense mesh stents, auxiliary stents, intratumoral embolization devices, aspiration devices, catheters, guide wires and other stroke ischemia products, providing patients with domestic alternatives to treat neurological diseases.

Contact Information

Website
www.neulive.cn
Formerly Known As
Jiangsu Shenchang Medical Technology, Shanghai Changda Medical Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 209B, Building 10
  • Number 1188 Lianhang Road, Minhang District
  • Shanghai
  • China
+86 021
Primary Industry
Therapeutic Devices
Corporate Office
  • Room 209B, Building 10
  • Number 1188 Lianhang Road, Minhang District
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuLive Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 13-Jan-2026 Completed Generating Revenue
6. Later Stage VC 13-Aug-2025 Completed Generating Revenue
5. Secondary Transaction - Private 13-Aug-2025 Completed Generating Revenue
4. Early Stage VC 05-Jul-2024 Completed Generating Revenue
3. Secondary Transaction - Private 15-Mar-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Dec-2021 Completed Generating Revenue
1. Early Stage VC 03-Mar-2021 Completed Generating Revenue
To view NeuLive Medical’s complete valuation and funding history, request access »

NeuLive Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuLive Medical Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wuhan Optics Valley Industrial Investment Growth/Expansion Minority
Anhui Capital Asset Manager Minority
CDBI Partners Venture Capital Minority
CreditEase Corporation Minority
Hangzhou Zhuyuan Investment Management Partnership Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

NeuLive Medical FAQs

  • When was NeuLive Medical founded?

    NeuLive Medical was founded in 2019.

  • Where is NeuLive Medical headquartered?

    NeuLive Medical is headquartered in Shanghai, China.

  • What is the size of NeuLive Medical?

    NeuLive Medical has 2 total employees.

  • What industry is NeuLive Medical in?

    NeuLive Medical’s primary industry is Therapeutic Devices.

  • Is NeuLive Medical a private or public company?

    NeuLive Medical is a Private company.

  • What is NeuLive Medical’s current revenue?

    The current revenue for NeuLive Medical is .

  • Who are NeuLive Medical’s investors?

    Wuhan Optics Valley Industrial Investment, Anhui Capital, CDBI Partners, CreditEase, and Hangzhou Zhuyuan Investment Management Partnership are 5 of 9 investors who have invested in NeuLive Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process